1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Cures Within Reach – Clinical Trials to Validate AI-Driven Drug Repurposing is sponsored by Cures Within Reach. This grant supports investigator-initiated, proof-of-concept, Phase I or Phase IIA clinical trials to validate artificial intelligence (AI)-driven repurposing opportunities in any unsolved disease.
The therapies supported by AI models must already be approved, and eligible trials must include AI-generated data as part of the preclinical support for the trial. This could be highly relevant for identifying existing drugs that AI suggests could be effective in colorectal cancer.
Get alerted about grants like this
Get emailed when new opportunities from “Cures Within Reach” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigator-initiated projects, likely targeting academic institutions and research organizations. Requires an institutional match. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000 (plus 10% institutional match). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 26, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Cures Within Reach – Clinical Trials to Validate AI-Driven Drug Repurposing is funded by Cures Within Reach. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
HRSA-26-078 splits $9.1 million among roughly 10 Public Health Training Centers, with awards up to $910,000 and applications due July 17, 2026. Eligibility runs to accredited schools of public health and other nonprofit training institutions. Here's why the winning applications are the ones that can prove an existing, mapped relationship with state and local health departments — not the ones promising the slickest coursework.
Read articleThe Department of Education's May 19 final rule activates Workforce Pell on July 1, 2026, opening federal aid to short-term training programs as brief as 8 weeks. Governors and state workforce boards — not accreditors — pick the eligible industries, and only programs that pass earnings-vs-cost gates make the list.
Read articleA new executive order, a DOJ National Fraud Enforcement Division, and a multi-agency task force are creating the most powerful federal grant enforcement apparatus in decades. What every recipient needs to understand.
Read article